Close
Nordic 9Nordic 9

Ackermans & van Haaren (investor - Others)

Belgium avh.be
See something wrong or missing? Let us know
Offices:Antwerp

Ackermans & van Haaren (AvH) is a Belgium based investment holding active in Marine Engineering & Contracting, Private Banking, Real estate and Senior Care, Energy & Resources, and Growth Capital.

Average round investment:57.58M USD
Average number per year:1.3
Distribution: 2025 (2)2024 (1)2023 (1)
Portfolio companies: Germany Disco PharmaceuticalsBelgium MRM HealthBelgium Confo Therapeutics See the entire list
Mostly invests in: Belgium Belgium (2) Health services (4)
See the entire list

Showing 3 of 4 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Ackermans & van Haaren

Name Criteria
United Kingdom 3i
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Israel aMoon
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
United States What If Ventures
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
United States Patient Square Capital
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Germany Evotec AG
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Pharma
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
United States Redmile Group
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Pharma
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Avego Bioscience Capital
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Spain Mutua Madrileña
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Switzerland HBM Healthcare Investments
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
United States HOF Capital
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Top